| Market Cap | ₹3,682Cr |
| ROE | 7.86% |
| P/E Ratio(TTM) | 43.21 |
| EPS(TTM) | 16.80 |
| P/B Ratio | 3.07 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.63 |
| Book Value | 236.35 |
| Debt to Equity | 0.14 |
| Face Value | 10 |
| Parent Organisation | Orchid Pharma |
| Managing Director | Shri. Manish Dhanuka |
| NSE Symbol | ORCHPHARMA |
| FUND NAME | AUM(%) |
|---|---|
| Quant Small Cap Fund Direct Plan Growth | 0.83% |
| UTI Healthcare Fund Direct Growth | 0.64% |
| UTI Value Fund Direct Growth | 0.54% |
| Nippon India Pharma Fund Direct Growth | 0.43% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |